Philip Morris PM financials
Consumer Staples ยท Statements and segments from its SEC filings, 2007 to 2025.
Philip Morris revenue, gross and operating margin, net income, free cash flow, cash and debt by quarter and by fiscal year, and revenue by segment, read from the company's own filings with the US Securities and Exchange Commission. Free to everyone; the Risk & Quality report that scores the company is the paid step.
- revenue by segment: Europe, SSEA, CIS & MEA, EA, AU & PMI GTR, Americas, International Combustibles, International Smoke-Free, U.S., Wellness & Healthcare
- revenue by product: Combustible Tobacco Products, Smoke-Free Products
- operating income by segment: Europe, SSEA, CIS & MEA, EA, AU & PMI GTR, Americas, European Union, East Asia & Australia, Middle East & Africa, South & Southeast Asia, Eastern Europe, Wellness & Healthcare, Swedish Match
The numbers
Annual figures
| Line | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.7B | $28.7B | $29.6B | $29.8B | $28.7B | $31.4B | $31.8B | $35.2B | $37.9B | $40.6B |
| Gross profit | $17.3B | $18.3B | $18.9B | $19.3B | $19.1B | $21.4B | $20.4B | $22.3B | $24.5B | $27.3B |
| Operating income | $10.9B | $11.6B | $11.4B | $10.5B | $11.7B | $13B | $12.2B | $11.6B | $13.4B | $14.9B |
| Net income | $7B | $6B | $7.9B | $7.2B | $8.1B | $9.1B | $9B | $7.8B | $7.1B | $11.3B |
| EPS (diluted) | $4.48 | $3.88 | $5.08 | $4.61 | $5.16 | $5.83 | $5.81 | $5.02 | $4.52 | $7.26 |
| Operating cash flow | $8.1B | $8.9B | $9.5B | $10.1B | $9.8B | $12B | $10.8B | $9.2B | $12.2B | $12.2B |
| Free cash flow | $6.9B* | $7.4B* | $8B* | $9.2B* | $9.2B* | $11.2B* | $9.7B* | $7.9B* | $10.8B* | $10.7B* |
| Cash & equivalents | $4.2B | $8.4B | $6.6B | $6.9B | $7.3B | $4.5B | $3.2B | $3.1B | $4.2B | $4.9B |
| Total debt | $25.9B | $31.3B | $27B | $26.7B | $28.2B | $24.8B | $34.9B | $41.2B | $42.2B | $45.1B |
| Gross margin | 64.8% | 63.7% | 63.7% | 64.7% | 66.7% | 68.1% | 64.1% | 63.3% | 64.8% | 67.1% |
| Operating margin | 40.9% | 40.3% | 38.4% | 35.3% | 40.7% | 41.3% | 38.6% | 32.9% | 35.4% | 36.6% |
| Net margin | 26.1% | 21.0% | 26.7% | 24.1% | 28.1% | 29.0% | 28.5% | 22.2% | 18.6% | 27.9% |
Latest quarters
| Line | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9B | $9.7B* | $9.3B | $10.1B | $10.8B | $10.4B* | $10.1B | $11.2B |
| Gross profit | $6.5B | $6.3B* | $6.3B | $6.9B | $7.4B | $6.8B* | $6.9B | $7.7B |
| Operating income | $3.7B | $3.3B* | $3.5B | $3.7B | $4.3B | $3.4B* | $3.9B | $4.5B |
| Net income | $3.1B | -$579M* | $2.7B | $3B | $3.5B | $2.1B* | $2.4B | $2.8B |
| EPS (diluted) | $1.97 | -$0.37* | $1.72 | $1.95 | $2.23 | $1.37* | $1.56 | $1.80 |
| Operating cash flow | $3.3B* | $4B* | -$350M | $3.4B* | $4.5B* | $4.7B* | -$399M | $5.5B* |
| Free cash flow | $3B* | $3.7B* | -$754M* | $3.1B* | $4.1B* | $4.3B* | -$752M* | $5.1B* |
| Cash & equivalents | $4.3B | $4.2B | $4.4B | $4.1B | $4B | $4.9B | $5.5B | $6B |
| Total debt | $44.2B | $42.2B | $38.8B | $42.4B | $41.9B | $45.1B | $43.8B | $42.4B |
| Gross margin | 66.0% | 64.7% | 67.4% | 67.7% | 67.8% | 65.6% | 68.1% | 68.4% |
| Operating margin | 36.9% | 33.6% | 38.1% | 36.6% | 39.3% | 32.6% | 38.4% | 40.5% |
| Net margin | 31.1% | -6.0% | 28.9% | 30.0% | 32.1% | 20.7% | 24.0% | 25.2% |
Revenue by segment
| Line | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Europe | $14.5B | $15.7B | $17.1B |
| SSEA, CIS & MEA | $10.6B | $11.3B | $12.1B |
| EA, AU & PMI GTR | $6.2B | $6.4B | $6.6B |
| Americas | $3.8B | $4.5B | $4.9B |
Revenue by product
| Line | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Combustible Tobacco Products | $22.3B | $23.2B | $23.8B |
| Smoke-Free Products | $12.8B | $14.7B | $16.9B |
Operating income by segment
| Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Europe | - | - | - | $5.3B | $6.5B | $7.2B |
| SSEA, CIS & MEA | - | - | - | $3.1B | $3.4B | $4.1B |
| EA, AU & PMI GTR | - | - | - | $2.5B | $2.9B | $3.1B |
| Americas | $564M | $487M | $436M | $582M | $548M | $505M |
| European Union | $5.1B | $6.1B | $5.8B | - | - | - |
| East Asia & Australia | $2.4B | $2.6B | $1.9B | - | - | - |
| Middle East & Africa | $1B | $1.1B | $1.8B | - | - | - |
| South & Southeast Asia | $1.7B | $1.5B | $1.5B | - | - | - |
| Eastern Europe | $871M | $1.2B | $1.2B | - | - | - |
| Wellness & Healthcare | $0 | -$52M | -$258M | - | - | - |
| Swedish Match | $0 | $0 | -$22M | - | - | - |
* derived: a fourth quarter as the year less the three filed quarters, or a remainder as the total less the parts. All other figures are as filed.
About this page
Every figure on this page is read from Philip Morris's own SEC filings: the statement lines from the SEC's XBRL company-facts feed, the revenue splits from the segment and revenue notes of each 10-K and 10-Q. Nothing is typed in or estimated. The cache refreshes daily.
Read the Risk & Quality report on Philip Morris or see all companies.